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pased on the guidelines for the management of
atients with ST-segment elevation myocardial in-
arction (STEMI), revascularization should not be
erformed in a noninfarct artery at the time of
rimary percutaneous coronary intervention. How-
ver, the timing of a staged intervention of the
onculprit vessel in these patients as well as other
ubsets including non–ST-segment elevation myo-
ardial infarction (NSTEMI), unstable angina, and
table angina patients are unclear. To obtain a real-
orld insight, the American College of Cardiology
onducted a survey of its Interventional Cardiology
ection on the frequently applied reasons for staging
rocedures and the related timing.
The American College of Cardiology (ACC)
nd the American Heart Association (AHA) pub-
ished guidelines for the management of patients
ith STEMI in 2004 (1) and guidelines for per-
utaneous coronary intervention (PCI) in 2005 (2).
ubsequent clinical trial data prompted their re-
pective focused updates in 2007 (3,4) and 2009
5). Although the guidelines address certain as-
ects of multivessel coronary artery disease includ-
ng deferment of revascularization of the nonin-
arct artery at the time of primary PCI in STEMI
atients without hemodynamic compromise (1),
ther facets including the timing of PCI of non-
ulprit vessels in STEMI and other subsets of
atients including NSTEMI, unstable angina
UA), and stable angina (SA) remain unclear. A
ariety of factors may affect the decision to stage a
rocedure and the time to schedule it. These can be
atient related (e.g., renal function), angiographic
e.g., lesion complexity), procedural (e.g., contrast
rom the *Mount Sinai Medical Center, New York, New York;
Deborah Heart and Lung Center, Browns Mills, New Jersey; ‡Chris-
iana Care Health System, Newark, Delaware; and the §Beth Israelt
eaconess Medical Center, Boston, Massachusetts. The authors have
eported that they have no relationships to disclose.edia volume and radiation dose used during the
rst lesion/vessel PCI), or other logistical reasons.
o obtain an insight into current real-world prac-
ice regarding the staging of PCI procedures, the
CC conducted an online survey and tabulated
esults from peers in interventional cardiology to
ormulate a consensus.
ethodology
n electronically distributed survey was conducted by
he market research department of the American
ollege of Cardiology from May through July 2010
sing an online questionnaire that was sent to 1,850
.S.-based interventional cardiology ACC members.
n initial invitation and 2 additional e-mail remind-
rs were sent periodically; a total of 411 members
articipated (22% response rate). A set of questions
ffecting the decisions and timing of staged PCI
rocedures was asked within the frame of 3 sepa-
ate clinical syndromes of presentation (i.e., acute
TEMI, NSTEMI/UA, and SA/elective PCI).
ecision to Stage
enal function was the single strongest factor in
he decision to stage a PCI. Accumulated contrast
se, lesion complexity, presentation with acute
oronary syndrome, and persistent symptomatol-
gy also influence the decision to stage (Fig. 1).
he least frequent reasons included logistical and
dministrative reasons.
Interventional cardiologists are most consistent
n their recommendation to stage the second PCI
t a later date when treating an STEMI patient
ith a concurrent high-grade proximal lesion in the
onculprit vessel who is hemodynamically stable after
rimary PCI as opposed to other clinical scenarios
resented. Four out of 5 (80%) recommend staging
he second PCI at a later date (Fig. 2).
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1097Figure 1. Factors Affecting Decision to StageRenal insufﬁciency and high contrast media volume are at the top and logistical/administrative reasons seem to be the least important. ACS  acute coronary syndromes.Figure 2. Decision to Stage in Patient Subsets
Signiﬁcant variability is observed, as ST-segment elevation myocardial infarction (STEMI) nonculprit vessel percutaneous coronary intervention (PCI) is rarely
practiced, in accordance to the guidelines. NSTEMI  non–ST-segment elevation myocardial infarction; SA  stable angina; UA  unstable angina.
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1098Cardiologists are mostly divided on their recommenda-
ions for treatment of a patient with NSTEMI or UA with
ultivessel coronary artery disease. Most (42%) opt for
reatment of the nonculprit vessel during the initial inter-
ention, whereas 37% would stage the second PCI at a later
ate, and 14% would only perform a second PCI based on
he development of persistent ischemia or symptoms (Fig. 2).
Cardiologists are mixed on their recommended treatment
f an elective SA patient with high-grade proximal stenoses
f all 3 proximal vessels. One-half (50%) would perform
CI of 1 or 2 vessels and then stage the second PCI at a
ater date, whereas 21% would perform PCI of all 3 vessels
n 1 setting, and 17% would perform PCI of 1 or 2 vessels
nd then only perform the second PCI based on the
evelopment of persistent ischemia or symptoms (Fig. 2).
iming of Staging
here was greater consistency in the timing of the second
CI stage. Only 18% to 25% wait longer than 30 days from
he initial procedure regardless of the clinical syndrome on
nitial presentation (Fig. 3).
The majority of cardiologists (62%) suggest a timeframe
f 15 days in STEMI patients for staging of the second
CI after the initial revascularization. In NSTEMI and UA
atients, cardiologists are more divided, with 55% recom-
Figure 3. Timing of Staging in Patient SubsetsThe majority of staged PCIs occur within a month of the original procedure. Abbrevending 2 weeks for the staged PCI after the initial
evascularization and 22% recommending complete revas-
ularization during the same hospitalization. In elective
table patients, the majority of cardiologists (64%) again
ecommend a timeframe of 15 days for the second PCI
fter the initial revascularization, with 35% recommending
CI within 2 weeks (Fig. 3).
mplications
taged PCI is a common clinical practice with multifactorial
ecision making. This survey found that the decisions
urrounding it are based on patient, angiographic, proce-
ural, and logistical reasons in decreasing rate of impor-
ance. Adjunct imaging and physiologic assessment may
lay a larger role in identifying important nonculprit lesions
nd in scheduling a staged PCI in the future. Multivessel
CI during the initial procedure seems to be practiced
nfrequently. In STEMI patients, this is exceedingly un-
ommon (2%) and routine staging is very common (80%).
Although performing a staged PCI after the first month
s a less frequent practice, its rate of approximately 20%
arrants further clarification. The current survey contained
more detailed breakdown of timing during the first month,
nd the results were mixed. Most opt for an outpatient
rocedure.iations as in Figure 2.
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1099In general, practice guidelines seem to be applied appro-
riately; on the other hand, they only exist in 1 clinical area
STEMI interventions). In the absence of guidelines, the
linical practice is quite mixed among the various choices.
hese findings can be amplified in the future with wider
articipation and further investigation of the interrelation-
hips of factors that may contribute to this complex decision
aking. A regional and operator-based variability of results
an be evaluated later.
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